论文部分内容阅读
作者在实验室与临床研究人类白细胞干扰素(HLI)已有10年经验的基础上,于1977年才开始系统地对一组头颈部肿瘤患者应用了干扰素进行治疗。现有的研究结果证明,干扰素除了具有抗病毒作用外,还有抗肿瘤的效果。干扰素抗肿瘤的基本生物学现象可分为干扰素的直接效应和对免疫系统的刺激作用.
Based on 10 years of experience in laboratory and clinical studies of human leukocyte interferon (HLI), the authors began to systematically apply interferon therapy to a group of head and neck cancer patients in 1977. The existing research results prove that interferon has anti-tumor effects in addition to its antiviral effect. The basic biological phenomena of interferon anti-tumor can be divided into the direct effect of interferon and the stimulatory effect on the immune system.